Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-22-021639

Options or other derivatives

  • Director acquired 30,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Harwin Peter Evan · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +30,700 30,700 D
Loading xslF345X03/doc4.xml…